Clinical Trial Update: Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated paclitaxel plus trastuzumab and pertuzumab as pre-operative therapy for inflammatory breast cancer; the trial is completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Breast Cancer

Drugs mentioned

• Paclitaxel (Taxol) (paclitaxel)
• Pertuzumab (Perjeta) (pertuzumab)
• Trastuzumab (Herceptin) (trastuzumab)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-09-05